GlassScriptPhysician profile
Besem Beteck
NPI 1649567736
$5,408.97
in general payments reported to CMS, 2019-2025
32 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,282 · 2020: $52.30 · 2021: $710 · 2022: $763 · 2023: $1,026 · 2024: $870 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,190 · Travel and Lodging: $411.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,189.53 |
| Travel and Lodging | $411.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,169.66 | 2021-2023 | Ellipsys Vascular Access System, Hawkone, Venaseal |
| Medtronic USA, INC. | $864.30 | 2019 | |
| W. L. Gore & Associates, INC. | $535.70 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Silk Road Medical, INC. | $371.89 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $235.96 | 2021-2022 | |
| Shockwave Medical, INC | $226.39 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $204.61 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bard Peripheral Vascular, INC. | $199.77 | 2021-2022 | |
| Endologix LLC | $178.05 | 2025 | Torus Stent Graft System, Endocross Device |
| Innovation Technologies INC | $164.61 | 2023-2024 | Irrisept |
| Kerecis Limited | $154.02 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Integra Lifesciences Corporation | $149.02 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sanara Medtech INC. | $136.81 | 2021 | |
| Artivion, INC. | $121.33 | 2021-2025 | Bioglue Surgical Adhesive, Vascular, Photofix Decellularized Bovine Pericardium |
| Tela Bio, INC. | $102.15 | 2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $86.96 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Cook Medical LLC | $86.54 | 2024 | Zenith Spiral-Z |
| Conmed Corporation | $62.50 | 2025 | Conmed Specimen Retrieval, Airseal |
| Becton, Dickinson and Company | $36.92 | 2024 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon |
| Acera Surgical, INC. | $36.17 | 2019-2025 | Restrata Wound Matrix |
| Boston Scientific Corporation | $35.19 | 2025 | Enroute Transcarotid Neuroprotection System |
| Angiodynamics, INC. | $31.71 | 2021 | |
| Stryker Corporation | $30.93 | 2025 | Artix Mt |
| Smith+Nephew, INC. | $28.83 | 2023 | Grafix Pl |
| Lemaitre Vascular, INC. | $26.72 | 2024 | Artegraft Vascular Graft |
| Ethicon US, LLC | $24.70 | 2025 | Stratafix |
| Penumbra, INC. | $21.13 | 2022 | |
| Access Pro Medical, LLC | $20.01 | 2023 | Matriderm |
| Abbott Laboratories | $18.89 | 2023 | Supera |
| Nevro Corp. | $18.79 | 2024 | Senza |
| Getinge USA Sales, LLC | $17.37 | 2022 | |
| Cardiovascular Systems INC. | $11.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Besem Beteck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.